LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) Operating income 2016–2025
LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) annual operating income history from SEC filings — each fiscal year as reported.
-$17.2MFY2025 · since FY2016: -$20.6M → -$17.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$17.2M | -95.0% |
| FY2024 | -$8.8M | +59.4% |
| FY2023 | -$21.8M | -84.9% |
| FY2022 | -$11.8M | -33.6% |
| FY2021 | -$8.8M | +65.9% |
| FY2020 | -$25.9M | -572.6% |
| FY2019 | $5.5M | -59.7% |
| FY2018 | $13.6M | -7.4% |
| FY2017 | $14.7M | +171.1% |
| FY2016 | -$20.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More LFCR financial trends
LFCR RevenueLFCR Net incomeLFCR Net marginLFCR Gross profitLFCR Gross marginLFCR Operating marginLFCR Operating cash flowLFCR Free cash flowLFCR Capital expendituresLFCR Return on equityLFCR Stock buybacksLFCR Dividends paidLFCR Total assetsLFCR Total liabilitiesLFCR Shareholders’ equityLFCR overview →